Medskin Ery


Erythromycin base ................................ 0.4 g
Excipients q.s .........................................10 g
(Hydroxypropyl cellulose, propylene glycol, doves flavor, ethanol 96%).
DOSAGE FORM: Dermal gel.
PRESENTATION: Box of 1 tube x 10 g.
PHARMACODYNAMICS: Medskin Ery contains the active ingredient erythromycin which is a macrolide antibiotic; it inhibits bacterial protein synthesis. Following local application to the skin, the drug inhibits the growth of susceptible bacteria and reduces the concentration of free fatty acids in sebum. These free fatty acids are irritants and are believed to cause acne. 
PHARMACOKINETICS: Medskin Ery has local actions.
INDICATIONS: Local treatment of acne, furuncle, inflammatory pustules.
CONTRAINDICATIONS: Hypersensitivity to any components of the drug.
PRECAUTIONS: Avoid contact with eyes, noses, mouth, mucosa, and open wounds. If accidental contact occurs, rinse thoroughly with water.
PREGNANCY AND LACTATION: Erythromycin should be used with cautions in pregnant women and nursing mothers because its safety has not been established when using local application.
The drug does not affect the ability to drive vehicles and operate machinery.
INTERACTIONS: Concurrent use with alcohol-containing cosmetics may also cause irritations or xeroderma. Use with cautions in patients concomitantly using with other local anti-acne drugs; especially those containing peeling, desquamating or abrasive agents. It is unadvised to apply dermal preparations containing erythromycin and clindamycin concomitantly because of possibly competitive binding for the 50S-ribosome subunits.
ADVERSE EFFECTS: A feeling of xeroderma may occur at the beginning of treatment. Mild acanthesthesia (maybe caused by alcohol excipients not by erythromycin) is reported.
Inform your physician about any adverse effects occur during the treatment.
OVERDOSAGE: No cases of Medskin Ery overdosage have been reported.
DOSAGE & ADMINISTRATION: A thin layer of gel should be applied to the cleansed affected areas twice daily.
As a rule, an 8-week treatment period will be necessary, but in instances of recurrence, the therapy period may be prolonged further.
Or as directed by the physician.
       Read the directions carefully before use.
       Consult the physician for more information.
       This drug is for prescriptions only.
     Shelf-life: 24 months from the manufacturing date.
     Storage conditions: Store in dry places, not exceeding 30oC; protect from light.
     Specifications: Manufacturer's.


There are yet no reviews for this product.